TC BioPharm (Holdings) plc - ADR

NASDAQ:TCBP  
0.73
-0.14 (-15.76%)
Products

TC Biopharm Announces FDA Orphan Drug Status Granted For Omnimmune®

Published: 03/17/2022 13:47 GMT
(TCBP) - Tc Biopharm Announces FDA Orphan Drug Status Granted for Omnimmune®.